Zilovertamab vedotin Antibody
Zilovertamab vedotin (VLS-101) is an ROR1-targeting antibody-drug conjugate that delivers the cytotoxic agent MMAE into cancer cells, inducing apoptosis. It is a research tool for investigating targeted therapies in both in vitro and in vivo models for various ROR1-positive malignancies, including chronic lymphocytic leukemia and mantle cell lymphoma.
Product Specifications
Target
ROR, Antibody-Drug Conjugates (ADCs)
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Metabolism Research
Molecular Weight
145.12 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
